查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1452456

磁性奈米粒子市場預測：~2030年

Magnetic Nanoparticles Market Research Report Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 104 Pages | 訂單完成後即時交付

價格

磁性奈米顆粒由於其特殊的性質，在不同領域有廣泛的應用。尤其廣泛應用於磁轉染、光熱療法、光動力療法、標靶藥物傳遞、磁熱療法等癌症治療。

據信，廢水處理產業對磁性奈米顆粒的需求不斷增加，這將為美國和中國的磁性奈米顆粒市場提供成長機會。

美國和中國的磁性奈米粒子市場預計將受到生物醫學和醫療保健領域擴張的推動。在預處理試劑盒過程中越來越多地使用磁性奈米顆粒技術正在推動美國磁性奈米顆粒市場的發展。

該報告調查了全球磁性奈米粒子市場，並提供了市場定義和概述、影響市場成長和市場機會的因素分析、市場規模趨勢和預測、各個細分市場和地區的細分以及競爭環境。其中彙編了主要公司的概況。

目錄

第 1 章市場概況

第二章 市場動態

  • 概述
  • 促進因素
    • 美國生物醫學和醫療保健產業的擴張
    • 中國生物醫學和醫療保健產業的擴張
    • 在預處理試劑盒中增加磁性奈米粒子技術的使用
  • 抑制因素
    • 中國磁性奈米粒子材料價格波動
    • 美國磁性奈米顆粒材料價格波動
    • 磁性奈米顆粒材料的毒性和生物相容性
  • 機會
    • 增加磁性奈米粒子在水處理的使用
  • 趨勢
    • 利用磁性分離和濃縮目標病原體的磁性奈米粒子核心技術
    • 使用磁性奈米顆粒 (MNPS) 的敗血症奈米診斷技術

第三章 磁性奈米粒子官能基與尺寸的定性分析

  • 按功能組
  • 按尺寸
  • 生物診斷中使用的基於磁珠的方法：概述

第四章 競爭狀況

  • 競爭對手分析
  • 市場佔有率分析
  • 主要成長策略（生物診斷最終用戶）
  • 競爭標桿
  • 開發數量領先
  • 主要發展/成長策略
  • 主要公司財務數據

第五章 公司簡介

  • QIAGEN NV
  • BIONEER CORPORATION
  • T2 BIOSYSTEMS, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • HOFFMANN-LA ROCHE LTD
  • CREATIVE BIOGENE
  • MAGGENOME TECHNOLOGIES PVT. LTD.
  • DAAN GENE CO., LTD.
  • MAGBIO GENOMICS INC.
  • BECKMAN COULTER INC.（DANAHER CORPORATION）
  • XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
  • GUANGZHOU DONGSHENG BIOTECH CO., LTD
  • GENEAID BIOTECH LTD.
  • TIANGEN BIOTECH(BEIJING)CO., LTD.
  • WUXI NEST BIOTECHNOLOGY CO., LTD

Market Overview

Magnetic nanoparticles define as the use of tiny particles that possess magnetic properties are typically ranging from 1 to 500 nanometres in size. Magnetic Nanoparticles is receptor immobilized magnetic nanoparticles bind specifically to bacteria and viruses. It is a core technology that can separate and concentrate target pathogens through magnetism. After directly synthesizing magnetic nanoparticles, self-coating is performed to prevent aggregation and then, various functional groups possessed are fixed to realize a concentrating effect. These nanoparticles are often composed of magnetic materials such as iron, cobalt, or nickel, or their alloys. They exhibit unique characteristics such as magnetic behavior at the nanoscale, which can be manipulated and controlled for various applications including wastewater treatment, electronics, healthcare sector, biomedical, energy and other application. Magnetic nanoparticles have a wide range of uses in different fields due to their special properties. Most notably, magnetic nanoparticles are frequently employed in cancer treatment methods like magnetofection, photothermal therapy, photodynamic therapy, targeted drug delivery, and magnetic hyperthermia.

However, the fluctuations in the prices of magnetic nanoparticles materials and toxicity and biocompatibility of magnetic nanoparticles materials will likely restrain market growth. On the other hand, to rise in demand for magnetic nanoparticles from wastewater industry will create growth opportunities for the US and China Magnetic Nanoparticles market.

Market Segmentation

The functional group of magnetic particles has been majorly classified into -COOH, -NH2, -SiO2, -Tosyl , and -Streptavidin.

The size range of magnetic particles has been majorly classified into 100, 200, 300, and 500 nm. The size of magnetic particles can greatly impact their magnetic behavior, surface area, stability, and interactions with other molecules or systems.

Regional Analysis

The US and China Magnetic Nanoparticles market is expected to be driven by increasing expansion of biomedical and healthcare sector in US and China. The Increase usage of magnetic nanoparticles technology in process of pretreatment kits are driving the US Magnetic Nanoparticles market.

Major Players

Qiagen N. V., Bioneer Corporation, T2 Biosystems Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Creative Biogene, Baker Coulters Inc. (Danaher Corporation), MagBio Genomics Inc., DaAn Gene Co., Ltd, and MagGenome Technologies Pvt. Ltd among others are the major companies in the Magnetic Nanoparticles Market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 DEFINITION
  • 1.2 SCOPE OF THE STUDY
  • 1.3 RESEARCH OBJECTIVE
  • 1.4 MARKET STRUCTURE
  • 1.5 LIST OF ASSUMPTIONS

2 MARKET DYNAMICS

  • 2.1 OVERVIEW
  • 2.2 DRIVERS
    • 2.2.1 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN US
    • 2.2.2 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN CHINA
    • 2.2.3 INCREASE USAGE OF MAGNETIC NANOPARTICLES TECHNOLOGY IN PRETREATMENT KITS
  • 2.3 RESTRAINTS
    • 2.3.1 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN CHINA
    • 2.3.2 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN US
    • 2.3.3 TOXICITY AND BIOCOMPATIBILITY OF MAGNETIC NANOPARTICLES MATERIALS
  • 2.4 OPPORTUNITIES
    • 2.4.1 INCREASING USE OF MAGNETIC NANOPARTICLES FOR WATER TREATMENT
  • 2.5 TRENDS
    • 2.5.1 CORE TECHNOLOGY OF MAGNETIC NANOPARTICLES THAT CAN SEPARATE AND CONCENTRATE TARGET PATHOGENS THROUGH MAGNETISM
    • 2.5.2 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS)

3 QUALITATIVE ANALYSIS ON FUNCTIONAL GROUP AND SIZE FOR MAGNETIC NANOPARTICLES

  • 3.1 BY FUNCTIONAL GROUP
  • 3.2 BY SIZE
  • 3.3 OVERVIEW OF MAGNETIC BEAD-BASED METHOD EMPLOYED IN BIO-DIAGNOSTICS

4 COMPETITIVE LANDSCAPE

  • 4.1 INTRODUCTION
  • 4.2 COMPETITIVE ANALYSIS
  • 4.3 MARKET SHARE ANALYSIS
  • 4.4 MAJOR GROWTH STRATEGY IN THE MAGNETIC NANOPARTICES MARKET (BIO-DIAGNOSTIC END USERS)
  • 4.5 COMPETITIVE BENCHMARKING
  • 4.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET
  • 4.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 4.7.1 PRODUCT LAUNCH/ PRODUCT DEVELOPMENT
    • 4.7.2 PARTNERSHIP/COLLABORATION
  • 4.8 MAJOR PLAYER FINANCIAL*
    • 4.8.1 SALES, OPERATING INCOME, R&D EXPENDITURE 2022*

5 COMPANY PROFILES

  • 5.1 QIAGEN NV
    • 5.1.1 COMPANY OVERVIEW
    • 5.1.2 FINANCIAL OVERVIEW
    • 5.1.3 PRODUCTS OFFERED
    • 5.1.4 KEY DEVELOPMENTS
    • 5.1.5 SWOT ANALYSIS
    • 5.1.6 KEY STRATEGIES
  • 5.2 BIONEER CORPORATION
    • 5.2.1 COMPANY OVERVIEW
    • 5.2.2 FINANCIAL OVERVIEW
    • 5.2.3 PRODUCTS OFFERED
    • 5.2.4 KEY DEVELOPMENTS
    • 5.2.5 SWOT ANALYSIS
    • 5.2.6 KEY STRATEGIES
  • 5.3 T2 BIOSYSTEMS, INC.
    • 5.3.1 COMPANY OVERVIEW
    • 5.3.2 FINANCIAL OVERVIEW
    • 5.3.3 PRODUCTS OFFERED
    • 5.3.4 KEY DEVELOPMENTS
    • 5.3.5 SWOT ANALYSIS
    • 5.3.6 KEY STRATEGIES
  • 5.4 THERMO FISHER SCIENTIFIC INC.
    • 5.4.1 COMPANY OVERVIEW
    • 5.4.2 FINANCIAL OVERVIEW
    • 5.4.3 PRODUCTS OFFERED
    • 5.4.4 KEY DEVELOPMENTS
    • 5.4.5 SWOT ANALYSIS
    • 5.4.6 KEY STRATEGIES
  • 5.5 HOFFMANN-LA ROCHE LTD
    • 5.5.1 FINANCIAL OVERVIEW
    • 5.5.2 PRODUCTS OFFERED
    • 5.5.3 KEY DEVELOPMENTS
    • 5.5.4 SWOT ANALYSIS
    • 5.5.5 KEY STRATEGIES
  • 5.6 CREATIVE BIOGENE
    • 5.6.1 COMPANY OVERVIEW
    • 5.6.2 FINANCIAL OVERVIEW
    • 5.6.3 PRODUCTS OFFERED
    • 5.6.4 KEY DEVELOPMENTS
    • 5.6.5 SWOT ANALYSIS
    • 5.6.6 KEY STRATEGIES
  • 5.7 MAGGENOME TECHNOLOGIES PVT. LTD.
    • 5.7.1 COMPANY OVERVIEW
    • 5.7.2 FINANCIAL OVERVIEW
    • 5.7.3 PRODUCTS OFFERED
    • 5.7.4 KEY DEVELOPMENTS
    • 5.7.5 SWOT ANALYSIS
    • 5.7.6 KEY STRATEGIES
  • 5.8 DAAN GENE CO., LTD.
    • 5.8.1 COMPANY OVERVIEW
    • 5.8.2 FINANCIAL OVERVIEW
    • 5.8.3 PRODUCTS OFFERED
    • 5.8.4 KEY DEVELOPMENTS
    • 5.8.5 SWOT ANALYSIS
    • 5.8.6 KEY STRATEGIES
  • 5.9 MAGBIO GENOMICS INC.
    • 5.9.1 COMPANY OVERVIEW
    • 5.9.2 FINANCIAL OVERVIEW
    • 5.9.3 PRODUCTS OFFERED
    • 5.9.4 KEY DEVELOPMENTS
    • 5.9.5 SWOT ANALYSIS
    • 5.9.6 KEY STRATEGIES
  • 5.10 BECKMAN COULTER INC. (DANAHER CORPORATION)
  • 5.10. COMPANY OVERVIEW
  • 5.10. FINANCIAL OVERVIEW
  • 5.10. PRODUCTS OFFERED

5.10.4KEY DEVELOPMENTS

5.10.5SWOT ANALYSIS

5.10.6KEY STRATEGIES

  • 5.11 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD

5.11.1COMPANY OVERVIEW

5.11.2FINANCIAL OVERVIEW

5.11.3PRODUCTS OFFERED

5.11.4KEY DEVELOPMENTS

5.11.5SWOT ANALYSIS

5.11.6KEY STRATEGIES

  • 5.12 GUANGZHOU DONGSHENG BIOTECH CO., LTD

5.12.1COMPANY OVERVIEW

5.12.2FINANCIAL OVERVIEW

5.12.3PRODUCTS OFFERED

5.12.4KEY DEVELOPMENTS

5.12.5SWOT ANALYSIS

5.12.6KEY STRATEGIES

  • 5.13 GENEAID BIOTECH LTD.

5.13.1COMPANY OVERVIEW

5.13.2FINANCIAL OVERVIEW

5.13.3PRODUCTS OFFERED

5.13.4KEY DEVELOPMENTS

5.13.5SWOT ANALYSIS

5.13.6KEY STRATEGIES

  • 5.14 TIANGEN BIOTECH(BEIJING)CO., LTD.98

5.14.1COMPANY OVERVIEW

5.14.2FINANCIAL OVERVIEW

5.14.3PRODUCTS OFFERED

5.14.4KEY DEVELOPMENTS

5.14.5SWOT ANALYSIS

5.14.6KEY STRATEGIES

  • 5.15 WUXI NEST BIOTECHNOLOGY CO., LTD

5.15.1COMPANY OVERVIEW

5.15.2FINANCIAL OVERVIEW

5.15.3PRODUCTS OFFERED

5.15.4KEY DEVELOPMENTS

5.15.5SWOT ANALYSIS

5.15.6KEY STRATEGIES

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 15
  • TABLE 2 PRODUCT LAUNCH/PRODUCT DEVELOPMENT 47
  • TABLE 3 PARTNERSHIP/COLLABORATION 48
  • TABLE 4 SALES, OPERATING INCOME, R & D EXPENDITURE 2022 49
  • TABLE 5 QIAGEN N.V.: PRODUCTS OFFERED 52
  • TABLE 6 QIAGEN N. V.: KEY DEVELOPMENTS 53
  • TABLE 7 BIONEER CORPORATION: PRODUCTS OFFERED 56
  • TABLE 8 BIONEER CORPORATION: KEY DEVELOPMENTS 57
  • TABLE 9 T2 BIOSYSTEMS, INC.: PRODUCTS OFFERED 60
  • TABLE 10 T2 BIOSYSTEMS, INC.: KEY DEVELOPMENTS 60
  • TABLE 11 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 64
  • TABLE 12 HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 68
  • TABLE 13 CREATIVE BIOGENE: PRODUCTS OFFERED 71
  • TABLE 14 MAGGENOME TECHNOLOGIES PVT. LTD.: PRODUCTS OFFERED 74
  • TABLE 15 MAGGENOME TECHNOLOGIES PVT. LTD.: KEY DEVELOPMENTS 75
  • TABLE 16 DAAN GENE CO., LTD: PRODUCTS OFFERED 78
  • TABLE 17 MAGBIO GENOMICS INC.: PRODUCTS OFFERED 81
  • TABLE 18 BECKMAN COULTER INC. (DANAHER CORPORATION): PRODUCTS OFFERED 85
  • TABLE 19 BECKMAN COULTER INC. (DANAHER CORPORATION): KEY DEVELOPMENTS 85
  • TABLE 20 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD: PRODUCTS OFFERED 88
  • TABLE 21 GUANGZHOU DONGSHENG BIOTECH CO., LTD: PRODUCTS OFFERED 92
  • TABLE 22 GENEAID BOITECH LTD.: PRODUCTS OFFERED 95
  • TABLE 23 GENEAID BOITECH LTD.: KEY DEVELOPMENTS 95
  • TABLE 24 TIANGEN BIOTECH (BEIJING) CO., LTD.: PRODUCTS OFFERED 99
  • TABLE 25 WUXI NEST BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 102

LIST OF FIGURES

  • FIGURE 1 MAGNETIC NANOPARTICLES MARKET: MARKET STRUCTURE 14
  • FIGURE 2 MARKET DYNAMICS: US AND CHINA MAGNETIC NANOPARTICLES MARKET 16
  • FIGURE 3 MARKET SIZE OF BIOMEDICAL INDUSTRY IN CHINA FROM 2015 TO 2019 (BILLION YUAN) 18
  • FIGURE 4 USE OF MNPS FOR BIOMEDICAL APPLICATIONS 19
  • FIGURE 5 SCHEMATIC PROCEDURE FOR NUCLEIC ACID PURIFICATION BY MEANS OF MAGNETIC NANOPARTICLE (MNPS) 21
  • FIGURE 6 DRIVERS: IMPACT ANALYSIS 22
  • FIGURE 7 PRICES FOR IRON ORE MARKET IN CHINA, 2019-2022, USD PER TONS 23
  • FIGURE 8 PRICES FOR IRON ORE MARKET IN US, 2019-2022, USD PER TONS 25
  • FIGURE 9 RESTRAINT: IMPACT ANALYSIS 27
  • FIGURE 10 RESTRAINT: IMPACT ANALYSIS 28
  • FIGURE 11 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS) 31
  • FIGURE 12 FIGURE A) REPRESENTS SCHEMATIC REPRESENTATION OF T2MR DIAGNOSTIC PLATFORM 32
  • FIGURE 13 FIGURE B) REPRESENTS NANOMAGNETO-DNA ASSAY FOR THE DETECTION OF BACTERIAL 16S RRNA 33
  • FIGURE 14 FIGURE C) REPRESENTS SERS SUBSTRATES TO ANCHOR ANTIBODY-DECORATED 34
  • FIGURE 15 MARKET SHARE ANALYSIS, 2022 43
  • FIGURE 16 COMPETITIVE BENCHMARKING 44
  • FIGURE 17 COMPETITIVE BENCHMARKING 45
  • FIGURE 18 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET (BIO-DIAGNOSTIC COMPANIES) 46
  • FIGURE 19 QIAGEN N. V.: FINANCIAL OVERVIEW SNAPSHOT 51
  • FIGURE 22 T2 BIOSYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT 59
  • FIGURE 24 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 63
  • FIGURE 26 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 67
  • FIGURE 29 MAGGENOME TECHNOLOGIES PVT. LTD.: SWOT ANALYSIS 75
  • FIGURE 30 DAAN GENE CO., LTD: SWOT ANALYSIS 79
  • FIGURE 32 BECKMAN COULTER INC. (DANAHER CORPORATION): FINANCIAL OVERVIEW SNAPSHOT 84
  • FIGURE 33 BECKMAN COULTER INC. (DANAHER CORPORATION): SWOT ANALYSIS 86